Crown Electrokinetics says Nasdaq declines request to reconsider delisting

Crown Electrokinetics (CRKN) announced that the Nasdaq Hearings Panel has declined Crown’s request to reconsider its March 3, 2025, decision to delist the Company’s common stock from The Nasdaq Stock Market. Following this determination, Crown immediately prepared and filed an appeal on March 18, 2025, requesting further review of the delisting decision. While this appeal does not guarantee reinstatement, it represents the next step in the process with Nasdaq. Crown remains committed to ensuring efficient trading and liquidity for its shareholders following the transition to the OTC market. The Company continues to work with its market makers and advisors to facilitate a smooth trading experience for investors.